Page 187 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 13 Chemokines and Hematopoietic Cell Trafficking 144.e1

REFERENCES 27. Ley K, Laudanna C, Cybulsky MI, et al: Getting to the site of inflam-
mation: the leukocyte adhesion cascade updated. Nat Rev Immunol
1. Steiner O, Coisne C, Cecchelli R, et al: Differential roles for endothe- 7(9):678–689, 2007.
lial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, 28. Hawkins PT, Stephens LR, Suire S, et al: PI3K signaling in neutrophils.
polarization, and directed crawling on blood-brain barrier endothelium. Curr Top Microbiol Immunol 346:183–202, 2010.
J Immunol 185(8):4846–4855, 2010. 29. Huang YE, Iijima M, Parent CA, et al: Receptor-mediated regulation
2. von Andrian UH, Mackay CR: T-cell function and migration. Two of PI3Ks confines PI(3,4,5)P3 to the leading edge of chemotaxing cells.
sides of the same coin. N Engl J Med 343(14):1020–1034, 2000. Mol Biol Cell 14(5):1913–1922, 2003.
3. Tomura M, Honda T, Tanizaki H, et al: Activated regulatory T cells 30. Gardiner EM, Pestonjamasp KN, Bohl BP, et al: Spatial and temporal
are the major T cell type emigrating from the skin during a cutaneous analysis of Rac activation during live neutrophil chemotaxis. Curr Biol
immune response in mice. J Clin Invest 120(3):883–893, 2010. 12(23):2029–2034, 2002.
4. Luster AD, Alon R, von Andrian UH: Immune cell migration in 31. Welch HC, Coadwell WJ, Ellson CD, et al: P-Rex1, a PtdIns(3,4,5)
inflammation: present and future therapeutic targets. Nat Immunol P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for
6(12):1182–1190, 2005. Rac. Cell 108(6):809–821, 2002.
5. Magnon C, Lucas D, Frenette PS: Trafficking of stem cells. Methods 32. Innocenti M, Frittoli E, Ponzanelli I, et al: Phosphoinositide 3-kinase
Mol Biol 750:3–24, 2011. activates Rac by entering in a complex with Eps8, Abi1, and Sos-1. J
6. Massberg S, Schaerli P, Knezevic-Maramica I, et al: Immunosurveil- Cell Biol 160(1):17–23, 2003.
lance by hematopoietic progenitor cells trafficking through blood, 33. Costa C, Barberis L, Ambrogio C, et al: Negative feedback regula-
lymph, and peripheral tissues. Cell 131(5):994–1008, 2007. tion of Rac in leukocytes from mice expressing a constitutively active
7. Mazo IB, Massberg S, von Andrian UH: Hematopoietic stem and phosphatidylinositol 3-kinase gamma. Proc Natl Acad Sci USA
progenitor cell trafficking. Trends Immunol 32(10):493–503, 2011. 104(36):14354–14359, 2007.
8. Massberg S, von Andrian UH: Novel trafficking routes for hematopoi- 34. Liu L, Puri KD, Penninger JM, et al: Leukocyte PI3Kgamma and
etic stem and progenitor cells. Ann N Y Acad Sci 1176:87–93, 2009. PI3Kdelta have temporally distinct roles for leukocyte recruitment in
9. Mendez-Ferrer S, Lucas D, Battista M, et al: Haematopoietic stem cell vivo. Blood 110(4):1191–1198, 2007.
release is regulated by circadian oscillations. Nature 452(7186):442–447, 35. Heit B, Liu L, Colarusso P, et al: PI3K accelerates, but is not required
2008. for, neutrophil chemotaxis to fMLP. J Cell Sci 121(Pt 2):205–214,
10. Dorie MJ, Maloney MA, Patt HM: Turnover of circulating hematopoi- 2008.
etic stem cells. Exp Hematol 7(9):483–489, 1979. 36. Lokuta MA, Senetar MA, Bennin DA, et al: Type Igamma PIP kinase
11. Goodman JW, Hodgson GS: Evidence for stem cells in the peripheral is a novel uropod component that regulates rear retraction during
blood of mice. Blood 19:702–714, 1962. neutrophil chemotaxis. Mol Biol Cell 18(12):5069–5080, 2007.
12. Fleming WH, Alpern EJ, Uchida N, et al: Steel factor influences the 37. Sarraj B, Massberg S, Li Y, et al: Myeloid-specific deletion of tumor
distribution and activity of murine hematopoietic stem cells in vivo. suppressor PTEN augments neutrophil transendothelial migration
Proc Natl Acad Sci USA 90(8):3760–3764, 1993. during inflammation. J Immunol 182(11):7190–7200, 2009.
13. Wright DE, Wagers AJ, Gulati AP, et al: Physiological migration of 38. Ghigo A, Damilano F, Braccini L, et al: PI3K inhibition in inflam-
hematopoietic stem and progenitor cells. Science 294(5548):1933–1936, mation: toward tailored therapies for specific diseases. Bioessays
2001. 32(3):185–196, 2010.
14. Rot A, von Andrian UH: Chemokines in innate and adaptive host 39. Hirsch E, Katanaev VL, Garlanda C, et al: Central role for G protein-
defense: basic chemokinese grammar for immune cells. Annu Rev coupled phosphoinositide 3-kinase gamma in inflammation. Science
Immunol 22:891–928, 2004. 287(5455):1049–1053, 2000.
15. Bromley SK, Mempel TR, Luster AD: Orchestrating the orchestrators: 40. Nishikimi A, Fukuhara H, Su W, et al: Sequential regulation of DOCK2
chemokines in control of T cell traffic. Nat Immunol 9(9):970–980, dynamics by two phospholipids during neutrophil chemotaxis. Science
2008. 324(5925):384–387, 2009.
16. Charo IF, Ransohoff RM: The many roles of chemokines and chemo- 41. Shulman Z, Pasvolsky R, Woolf E, et al: DOCK2 regulates chemokine-
kine receptors in inflammation. N Engl J Med 354(6):610–621, 2006. triggered lateral lymphocyte motility but not transendothelial migra-
17. Griffith JW, Sokol CL, Luster AD: Littman DR, Yokoyama WM, tion. Blood 108(7):2150–2158, 2006.
editors: Annual Review of Immunology (vol 32), Palo Alto, 2014, Annual 42. Nombela-Arrieta C, Mempel TR, Soriano SF, et al: A central role for
Reviews, pp 659–702. DOCK2 during interstitial lymphocyte motility and sphingosine-1-
18. Zlotnik A, Yoshie O: The chemokine superfamily revisited. Immunity phosphate-mediated egress. J Exp Med 204(3):497–510, 2007.
36(5):705–716, 2012. 43. Willars GB: Mammalian RGS proteins: multifunctional regulators of
19. Wettschureck N, Offermanns S: Mammalian G proteins and their cell cellular signalling. Semin Cell Dev Biol 17(3):363–376, 2006.
type specific functions. Physiol Rev 85(4):1159–1204, 2005. 44. Sethakorn N, Yau DM, Dulin NO: Non-canonical functions of RGS
20. Alon R, Shulman Z: Chemokine triggered integrin activation and proteins. Cell Signal 22(9):1274–1281, 2010.
actin remodeling events guiding lymphocyte migration across vascular 45. Brzostowski JA, Kimmel AR: Signaling at zero G: G-protein-indepen-
barriers. Exp Cell Res 317(5):632–641, 2011. dent functions for 7-TM receptors. Trends Biochem Sci 26(5):291–297,
21. Nomiyama H, Osada N, Yoshie O: A family tree of vertebrate che- 2001.
mokine receptors for a unified nomenclature. Dev Comp Immunol 46. Ulvmar MH, Hub E, Rot A: Atypical chemokine receptors. Exp Cell
35(7):705–715, 2011. Res 317(5):556–568, 2011.
22. Sharma M: Chemokines and their receptors: orchestrating a fine balance 47. Pruenster M, Mudde L, Bombosi P, et al: The Duffy antigen receptor
between health and disease. Crit Rev Biotechnol 30(1):1–22, 2009. for chemokines transports chemokines and supports their promigratory
23. Horuk R, Proudfoot AE: Drug discovery targeting the chemokine activity. Nat Immunol 10(1):101–108, 2009.
system—where are we? Front Biosci (Elite Ed) 1:209–219, 2009. 48. Nibbs RJ, Graham GJ: Immune regulation by atypical chemokine
24. Murphy PM: International Union of Pharmacology. XXX. Update receptors. Nat Rev Immunol 13(11):815–829, 2013.
on chemokine receptor nomenclature. Pharmacol Rev 54(2):227–229, 49. Bachelerie F, Ben-Baruch A, Burkhardt AM, et al: International Union
2002. of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update
25. Kenakin T, Onaran O: The ligand paradox between affinity and on the extended family of chemokine receptors and introducing a
efficacy: can you be there and not make a difference? Trends Pharmacol new nomenclature for atypical chemokine receptors. Pharmacol Rev
Sci 23(6):275–280, 2002. 66(1):1–79, 2014.
26. Kenakin T: Ligand-selective receptor conformations revisited: the 50. Liu Z, Christensson M, Forslow A, et al: A CD26-controlled cell
promise and the problem. Trends Pharmacol Sci 24(7):346–354, surface cascade for regulation of T cell motility and chemokine signals.
2003. J Immunol 183(6):3616–3624, 2009.